Respironics closes Profile acquisition:
This article was originally published in Clinica
Respironics, the Murrysville, Pennsylvania respiratory products maker, has completed the $46m acquisition of its UK distributor, Profile Therapeutics. A spokesperson for Profile said Respironics did not plan any redundancies or major changes at the Bognor Regis, Sussex-based firm, which has its own range of inhalation technologies. Existing management will continue to run the business, as a subsidiary of Respironics. Profile says becoming part of a large global group should help accelerate its R&D plans.